Modified MR scoring system for assessment of sonographically indeterminate ovarian and adnexal masses in the absence of dynamic contrast-enhanced
- PMID: 38263830
- PMCID: PMC11027275
- DOI: 10.1093/bjr/tqad005
Modified MR scoring system for assessment of sonographically indeterminate ovarian and adnexal masses in the absence of dynamic contrast-enhanced
Abstract
Objectives: Dynamic contrast-enhanced (DCE) MRI is not available in all imaging centres to investigate adnexal masses. We proposed modified magnetic resonance (MR) scoring system based on an assessment of the enhancement of the solid tissue on early phase postcontrast series and diffusion-weighted imaging (DWI) with apparent diffusion coefficient (ADC) map and investigated the validity of this protocols in the current study.
Materials and methods: In this cross-sectional retrospective study, pelvic MRI of a total of 245 patients with 340 adnexal masses were studied based on the proposed modified scoring system and ADNEX MR scoring system.
Results: Modified scoring system with the sensitivity of 87.3% and specificity of 94.6% has an accuracy of 92.1%. Sensitivity, specificity, and accuracy of ADNEX MR scoring system is 96.6%, 91%, and 92.9%, respectively. The area under the receiver operating characteristic curve for the modified scoring system and ADNEX MR scoring system is 0.909 (with 0.870-0.938 95% confidence interval [CI]) and 0.938 (with 0.907-0.961 95% CI), respectively. Pairwise comparison of these area under the curves showed no significant difference (P = .053).
Conclusions: Modified scoring system is less sensitive than the ADNEX MR scoring system and more specific but the accuracy is not significantly different.
Advances in knowledge: According to our study, MR scoring system based on subjective assessment of the enhancement of the solid tissue on early phase postcontrast series and DWI with ADC map could be applicable in imaging centres that DCE is not available.
Keywords: ADNEX MR scoring system; adnexal mass; diffusion-weighted imaging; dynamic contrast-enhanced images; pelvic MRI.
© The Author(s) 2023. Published by Oxford University Press on behalf of the British Institute of Radiology. All rights reserved. For permissions, please email: journals.permissions@oup.com.
Conflict of interest statement
Nothing to declare.
Figures





References
-
- Ferlay J, Soerjomataram I, Dikshit R, et al.Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359-E386. - PubMed
-
- Coccia ME, Rizzello F, Romanelli C, Capezzuoli T.. Adnexal masses: what is the role of ultrasonographic imaging? Arch Gynecol Obstet. 2014;290(5):843-854. - PubMed
-
- Meys EM, Kaijser J, Kruitwagen RF, et al.Subjective assessment versus ultrasound models to diagnose ovarian cancer: a systematic review and meta-analysis. Eur J Cancer. 2016;58:17-29. - PubMed
-
- Froyman W, Landolfo C, De Cock B, et al.Risk of complications in patients with conservatively managed ovarian tumours (IOTA5): a 2-year interim analysis of a multicentre, prospective, cohort study. Lancet Oncol. 2019;20(3):448-458. - PubMed
-
- Alcázar J, Pascual M, Graupera B, et al.External validation of IOTA simple descriptors and simple rules for classifying adnexal masses. Ultrasound Obstet Gynecol. 2016;48(3):397-402. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical